Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease	Recruiting	Not stated	2022-07-08		NCT05447169

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Changsha Central Hospital	6
First People's Hospital of Foshan	44
Hunan Cancer Hospital	66
Sun Yat-sen University	606
The Third Affiliated Hospital of Nanchang University	2
Wuzhou Red Cross Hospital	20
Xiangya Hospital of Central South University	162
Yuebei People's Hospital	14
Zhongshan People's Hospital, Guangdong, China	46

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center	Guangzhou	China	5